The weekly litigation news digest is live. Subscribe now

Patent Oppositions in form specific drugs industry

Explore the competitive field of form specific drugs where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in form specific drugs technology and learn how to protect your intellectual property.

Get Patent Opposition Report for form specific drugs

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Report

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the form specific drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the form specific drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Nov 20, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name
Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-DioneAMGEN EUROPEOct 24, 2025CAMULON
Urolithin A And A Composition Containing Same For External Use In Inflammations Of Various EtiologiesMICROBIOTA MED SP Z OOOct 15, 2025AMAZENTIS
Use Of Whey Protein Micelles For Controlling Postprandial Glucose ResponseNESTLEOct 15, 2025ARLA FOODS AMBA
Methods For Treating Hypertrophic CardiomyopathyCYTOKINETICSOct 14, 2025HAMM & WITTKOPP
Use Of Whey Protein Micelles For Controlling Postprandial Glucose ResponseNESTLEOct 13, 2025FRESENIUS KABI DEUTSCHLAND
New Cannabis Compositions And Industrial Methods For Production ThereofBUZZELETOct 8, 2025ALTMANN STOSSEL DICK PATENTANWALTE PARTG MBB
Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-DioneAMGEN EUROPEOct 1, 2025ELKINGTON AND FIFE
Combination Therapy For Inhalation AdministrationCHEMO RESEARCHOct 1, 2025HIGHTONE MANAGEMENT
Product Comprising A Container And Whey ProteinCOMPAGNIE GERVAIS DANONESep 23, 2025NESTLE
Product Comprising A Container And Whey ProteinCOMPAGNIE GERVAIS DANONESep 15, 2025FRESENIUS KABI DEUTSCHLAND

To stay ahead in the competitive form specific drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the form specific drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Nov 20, 2025
Patent NumberPublication DateTitleApplicantTotal Oppositions
Jan 17, 2024Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIM19
Nov 13, 2019Apixaban FormulationsBRISTOL MYERS SQUIBB IRELAND UNLIMITED12
Aug 18, 2021Formulations Of EnzalutamideMEDIVATION PROSTATE THERAPEUTICS12
Dec 11, 2019Rapid Dissolution Formulation Of A Cinacalcet HclAMGEN12
May 10, 2017Pharmaceutical Preparation Containing Oxycodone And NaloxoneNAPP PHARMACEUTICAL11
May 10, 2017Pharmaceutical Preparation Containing Oxycodone And NaloxoneMUNDIPHARMA11
Dec 5, 2018Apixaban FormulationsBRISTOL MYERS SQUIBB IRELAND UNLIMITED10
Dec 11, 2019Pharmaceutical Composition Containing Glycopyrrolate And A Beta2 Adrenoceptor AgonistNOVARTIS10
Oct 16, 2019Apixaban FormulationsPFIZER10
Mar 2, 2022Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNA10